Table 1.
Patient | Genotype | Log OM-OH index | Primary cancer | Metastases | AST | ALT | BT | BD | Alkaline phosphatase | LDH | Albumin |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | *2/wt | 1.41 | Lung | Liver, kidney, brain | ⇑ * | ⇑ * | N/A | N/A | ⇑ * | ⇓ * | ⇓ * |
2 | wt/wt | 1.28 | |||||||||
3 | wt/wt | 1.14 | Lung | Pleura | ⇑ | ⇑ | N/A | ⇔ | ⇑ | ⇔ * | ⇔ |
4 | wt/wt | 1.04 | Unknown | Liver, bone, duodenum, adrenal | ⇔ | ⇔ | ⇔ | ⇔ | ⇑ | ⇑ | ⇓ * |
5 | *2/wt | 0.98 | Colon | Liver, lung, spleen | ⇑ | ⇓ | ⇔ | ⇔ | ⇑ * | ⇑ * | ⇓ |
6 | wt/wt | 0.94 | Lung | Pleura | ⇑ | ⇑ | ⇔ | ⇔ | ⇑ | ⇑ * | ⇔ |
7 | wt/wt | 0.91 | Unknown | Lung, bone, breast, brain | ⇑ | ⇓ | ⇔ | ⇔ | ⇑ | ⇑ | ⇔ |
8 | wt/wt | 0.90 | Lung | Liver, bone | ⇔ | ⇓ | ⇔ | ⇔ | ⇑ * | ⇑⇓ | ⇓ |
9 | *2/wt | 0.80 | Breast | Lung, bone, brain | ⇓ | ⇓ | ⇔ | ⇔ | ⇑⇓ | ⇔ * | ⇓ |
10 | wt/wt | 0.70 | Lung | Pleura | ⇑ | ⇑ | ⇔ | ⇔ | ⇑⇓ | ⇑⇓ * | ⇓ |
11 | wt/wt | 0.63 | Unknown | Liver | N/A | N/A | ⇔ | ⇔ | N/A | N/A | N/A |
12 | *2/wt | 0.54 | Stomach | Kidney | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
13 | wt/wt | 0.49 | Pancreas | Liver | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
14 | wt/wt | 0.46 | Breast | Liver, lung, pleura | ⇑⇓ * | ⇔ | ⇔ | ⇔ | ⇑⇓ * | ⇑⇓ * | ⇓ |
15 | wt/wt | 0.34 | Oesophagus | Liver | ⇓ | ⇑ | ⇔ | ⇔ | ⇑⇓ | ⇑ * | ⇑⇓ |
16 | wt/wt | 0.32 | Colon | Liver, rectum, lung | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
No medical records were available for patient 2. AST = aspartate aminotransferase, ALT = alanine aminotransferase, BT = total bilirubin, BD = bilirubin direct, LDH = lactate dehydrogenase. ⇑ Increasing at time of phenotyping, ⇓ Decreasing at time of phenotyping, ⇔ Stable at time of phenotyping, ⇑⇓ Fluctuating around the time of phenotyping.
Levels out of normal range; where this is absent, levels are within the normal range. N/A = No data available at the time of phenotyping.